Form 8-K - Current report:
SEC Accession No. 0001641172-25-011936
Filing Date
2025-05-21
Accepted
2025-05-21 17:25:09
Documents
15
Period of Report
2025-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45710
2 EX-10.1 ex10-1.htm EX-10.1 34993
3 GRAPHIC ex10-1_001.jpg GRAPHIC 3765
  Complete submission text file 0001641172-25-011936.txt   263926

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mira-20250515.xsd EX-101.SCH 3047
5 XBRL LABEL FILE mira-20250515_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE mira-20250515_pre.xml EX-101.PRE 22380
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3814
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
Type: 8-K | Act: 34 | File No.: 001-41765 | Film No.: 25974092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)